Advertisement

The Effects of β Blockade and Partial Agonist Activity during Myocardial Ischemia

  • A. S. Manning
  • J. M. Keogh
  • D. J. Coltart
  • D. J. Hearse

Abstract

In this study, we have investigated the importance of partial agonist activity during myocardial ischemia by comparing the effects of equiblocking doses of Oxprenolol, which possesses partial agonist activity, to propranolol which does not. In the isolated, globally ischemic (low-flow) rat heart, when propranolol or Oxprenolol was added alone during the ischemic period, only propranolol reduced enzyme leakage relative to control. However, when the hearts were perfused (10 min) prior to ischemia with these drugs, both ß blockers caused a significant reduction in enzyme leakage. Under conditions of enhanced sympathetic drive (in the presence of 0.01 |xm isoproterenol), both ß blockers reduced enzyme leakage to differing extents. In hearts with low sympathetic drive (reserpine pretreatment), enzyme leakage was unaffected by propranolol and exacerbated by Oxprenolol. The results of this study suggest that Oxprenolol and propranolol influence ischemic damage to differing extents and that this difference is due to partial agonist activity. Also, the protective action of all ß-blocking compounds depends greatly on the background level of sympathetic drive.

Keywords

Contractile Activity Ischemic Damage Enzyme Release Perfusion Fluid Ischemic Period 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    De Leins, J., Peyrot, M., and Feuvray, D. 1978. Pharmacological reduction of ischaemia-induced enzyme release from isolated rat hearts. J. Mol. Med. 3:111–121.Google Scholar
  2. 2.
    Dhalla, N. S., Lee, S. L., Anand, M. B., and Chauhan, M. S. 1977. Effects of acebutolol, practolol and propranolol on the rat heart sarcolemma. Biochem. Pharmacol. 26:2055–2060.PubMedCrossRefGoogle Scholar
  3. 3.
    Hearse, D. J., Garlick, P. B., Humphrey, S. M., and Shillingford, J. P. 1978. The effect of drugs on enzyme release from the hypoxic myocardium. Eur. J. Cardiol. 7:421–436.PubMedGoogle Scholar
  4. 4.
    Hearse, D. J., Humphrey, S. M., and Bullock, G. R. 1978. The oxygen paradox and the calcium paradox: Two facets of the same problem? J. Mol. Cel. Cardiol. 10:641–668.CrossRefGoogle Scholar
  5. 5.
    Kloner, R., Fishbein, M., Braunwald, E., and Maroko, P. 1977. Effect of propranolol on mitochondrial morphology during acute myocardial ischemia. Am. J. Cardiol. 55:872–886.Google Scholar
  6. 6.
    Krebs, H. A., and Henseleit, K. 1932. Untersuchungen über die Harnstoffbildung im Tierkörper. Hoppe Seylers Z. Physiol. Chem. 210:33–66.CrossRefGoogle Scholar
  7. 7.
    Manning, A. S., Hearse, D. J., Dennis, S. C, Bullock, G. R., and Coltart, D. J. 1980. Myocardial ischaemia: An isolated, globally perfused rat heart model for metabolic and pharmacological studies. Eur. J. Cardiol. 11:1–21.PubMedGoogle Scholar
  8. 8.
    Maroko, P. R., Kjekshus, J. K., Sobel, B. E., Watanabe, T., Covell, J. W., Ross, J., and Braunwald, E. 1971. Factors influencing infarct size following experimental coronary artery occlusions. Circulation 43:67–82.PubMedCrossRefGoogle Scholar
  9. 9.
    Marshall, R. J., and Parratt, J. R. 1976. Comparative effects of propranolol and practolol in the early stages of experimental canine myocardial infarction. Br. J. Pharmacol. 57:295–303.PubMedCrossRefGoogle Scholar
  10. 10.
    Nayler, W., Grau, A., and Yepez, C. 1977. Beta-adrenoceptor antagonists and the release of creatine Phosphokinase from hypoxic heart muscle. Cardiovasc. Res. 11:344–352.PubMedCrossRefGoogle Scholar
  11. 11.
    Oliver, J. 1965. A spectrophotometry method for the determination of creatine Phosphokinase and myokinase. Biochem. J. 61:116–122.Google Scholar
  12. 12.
    Reimer, K., Rasmussen, M., and Jennings, R. 1973. Reduction by propranolol of myocardial necrosis following temporary coronary artery occlusion in dogs. Circ. Res. 33:353–363.PubMedCrossRefGoogle Scholar
  13. 13.
    Scott, E., Truog, A., Rogg, H., and Meier, M. 1979. Effect of propranolol during different degrees of hypoxia in the isolated guinea-pig heart. J. Mol. Cell. Cardiol. 11(Suppl. 2):54.Google Scholar
  14. 14.
    Serano, P. A., Chavez-Lara, B., Bisteni, A., and Sodi-Pallares, D. 1971. Effect of propranolol on catecholamine content of injured cardiac tissue. J. Mol. Cell Cardiol. 2:91–97.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1983

Authors and Affiliations

  • A. S. Manning
    • 1
  • J. M. Keogh
    • 1
  • D. J. Coltart
    • 1
  • D. J. Hearse
    • 1
  1. 1.The Myocardial Metabolism and Cardiac Pharmacology UnitsThe Rayne InstituteLondon SE1England

Personalised recommendations